Taking people in United StatesPhase 4
Testing a Device for Acute Ischemic Stroke in Adults
Tests the Route 92 reperfusion device in adults having an acute stroke.
Plain-language title generated from the registry record
Registry title: SUMMIT RISE Study of Acute Ischemic Stroke Patients
Key facts
- Where
- West Jordan, United StatesSee the site
- Phase
- Phase 4
Where in United States
- Route 92 Medical, Inc.West Jordan, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Route 92 Medical, Inc.
- Trial code
- NCT07436156
- Record updated
- 27 February 2026
- Original description
SUMMIT RISE Study of Acute Ischemic Stroke PatientsRead full original descriptionShow less
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Inclusion: Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System; Informed consent completed and documented within 72 hours following thrombectomy procedure; Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well; Age ≥ 18 years.
Exclusion: None.